表紙
市場調査レポート

球様細胞白質萎縮症 (クラッベ病):世界の治験レビュー

Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 308249
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
球様細胞白質萎縮症 (クラッベ病):世界の治験レビュー Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014
出版日: 2014年06月30日 ページ情報: 英文 70 Pages
概要

当レポートでは、世界の主要地域おける球様細胞白質萎縮症 (クラッベ病)治療薬の治験数や被験者数、段階別の動向、主要企業や機関、治験のプロファイルなどをまとめています。

イントロダクション

  • 球様細胞白質萎縮症 (クラッベ病)
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系疾患の治験件数に対する球様細胞白質萎縮症 (クラッベ病)の治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系疾患の治験件数に対する球様細胞白質萎縮症 (クラッベ病)の治験件数比率

E7諸国における段階別の治験件数

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数 球様細胞白質萎縮症 (クラッベ病)

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

球様細胞白質萎縮症 (クラッベ病)の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Zymenex A/S
    • Shire Plc
    • Fate Therapeutics, Inc.
    • Cytomedix, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Masonic Cancer Center
    • University of Rostock
    • Fairview University Medical Center
    • New York Medical College
    • Center for International Blood and Marrow Transplant Research
    • University of Chicago
    • University of Louisville
    • National Center for Research Resourcess
    • National Cancer Institute
    • University of Pittsburgh

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2228CTIDB

GlobalData's clinical trial report, "Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2014" provides data on the Globoid Cell Leukodystrophy (Krabbe Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Globoid Cell Leukodystrophy (Krabbe Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Globoid Cell Leukodystrophy (Krabbe Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Globoid Cell Leukodystrophy (Krabbe Disease)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Globoid Cell Leukodystrophy (Krabbe Disease)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Zymenex A/S
      • Clinical Trial Overview of Zymenex A/S
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Fate Therapeutics, Inc.
      • Clinical Trial Overview of Fate Therapeutics, Inc.
      • Cytomedix, Inc.
      • Clinical Trial Overview of Cytomedix, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Masonic Cancer Center
      • Clinical Trial Overview of Masonic Cancer Center
      • University of Rostock
      • Clinical Trial Overview of University of Rostock
      • Fairview University Medical Center
      • Clinical Trial Overview of Fairview University Medical Center
      • New York Medical College
      • Clinical Trial Overview of New York Medical College
      • Center for International Blood and Marrow Transplant Research
      • Clinical Trial Overview of Center for International Blood and Marrow Transplant Research
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • University of Louisville
      • Clinical Trial Overview of University of Louisville
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zymenex A/S, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fate Therapeutics, Inc., 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytomedix, Inc., 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rostock, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fairview University Medical Center, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by New York Medical College, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for International Blood and Marrow Transplant Research, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*

List of Figures

  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top